MKD_BMT Profile Banner
Mohamed Kharfan-Dabaja, MD, MBA Profile
Mohamed Kharfan-Dabaja, MD, MBA

@MKD_BMT

Followers
2K
Following
1K
Media
179
Statuses
457

Vice Chair of Hematology. Director of Blood Marrow and Transplantation and Cellular Therapies.@MayoClinic @MayoCancerCare

Jacksonville, FL
Joined May 2021
Don't wanna be here? Send us removal request.
@DrAEvens
Andrew M. Evens, DO, MBA, MSc
20 days
🗼Great to be at the @TheIACH #IACH2025 meeting 🇫🇷, including a lovely & informative talk by @Jessica_Okosun on transformed #lymphoma. 🙌 And Kudos to lymphoma chairs @StefanoLuminari, @AnnaSureda5, @MKD_BMT & @MediHumdani for putting together excellent talks & timely topics!
1
8
36
@MKD_BMT
Mohamed Kharfan-Dabaja, MD, MBA
20 days
Outstanding presentation by @JulioChavezMD on impact of novel therapies in follicular lymphoma @TheIACH #COLYM in Paris, France 🇫🇷 @AnnaSureda5 @Mohty_EBMT @MediHumdani @StefanoLuminari
2
10
50
@nourmoukalled
Nour Moukalled
2 months
At the 2025 CAR-T Day @i_yakoub_agha 2 days full of science and innovation
0
3
18
@RManochakian
Rami Manochakian MD, FASCO Cancer Education
2 months
📣🚨Alerting #Oncology colleagues & #fellows to a great academic #GIOncology career opportunity. The #Hem/#Onc Division @MayoClinic @MayoCancerCare in #Florida is seeking: ✅A #MedicalOncologist with interest/expertise in #Gastrointestinal #Cancers. 👇🏻 https://t.co/6PkQ0URx0F
2
18
58
@MKD_BMT
Mohamed Kharfan-Dabaja, MD, MBA
3 months
Inspiring presentation on management of aggressive non-Hodgkin lymphomas by @AlhajMoustafa during the @MayoClinic 34th Annual Hematology-Oncology Reviews in Amelia Island, FL @MayoCancerCare @RManochakian @MadihaIqbal13 @JulioChavezMD
7
3
43
@MKD_BMT
Mohamed Kharfan-Dabaja, MD, MBA
3 months
Great update on management of CD30+ non-Hodgkin lymphomas by @MadihaIqbal13 at the @MayoClinic 34th Annual Hematology-Oncology Reviews in Amelia Island, FL @MayoCancerCare @RManochakian @JulioChavezMD @AlhajMoustafa @hemant_murthy
1
4
26
@oncodaily
OncoDaily
3 months
0
3
21
@MKD_BMT
Mohamed Kharfan-Dabaja, MD, MBA
3 months
Great presentation by @CaThompsonMD on management of low-grade non-Hodgkin lymphoma @MayoClinic 34th Annual Hematology-Oncology Reviews in Amelia Island, FL @RManochakian @MadihaIqbal13 @AlhajMoustafa @hemant_murthy @MayoCancerCare
1
3
19
@MKD_BMT
Mohamed Kharfan-Dabaja, MD, MBA
3 months
Excellent update on myelodysplastic syndrome prognostication and therapeutics by @hemant_murthy at the @MayoClinic 34th Annual Hematology-Oncology Reviews in Amelia Island, FL @RManochakian @MadihaIqbal13 @MayoCancerCare
1
4
13
@MKD_BMT
Mohamed Kharfan-Dabaja, MD, MBA
3 months
Great lecture by Dr. James Foran from @MayoCancerCare in Jacksonville on updates in management of acute lymphoblastic leukemia during the 34th @MayoClinic Annual Hematology-Oncology Reviews in Amelia Island, FL @hemant_murthy @TalhaBadarMD @RManochakian @MadihaIqbal13
1
6
26
@MKD_BMT
Mohamed Kharfan-Dabaja, MD, MBA
3 months
Outstanding lecture on updates of acute myeloid leukemia management in 2025 by @Razan_Mohty at the 34th Annual @MayoCancerCare Hematology-Oncology Reviews in Amelia Island, FL @RManochakian @MadihaIqbal13 @hemant_murthy
0
7
20
@RManochakian
Rami Manochakian MD, FASCO Cancer Education
3 months
🔥📣Excited to kick off the 34th annual @MayoCancerCare Florida #Hematology/#Oncology Reviews 2025 ✅Comprehensive #CME #Practical (in-person & virtual) conference on new clinical advancements in #Hematology & #CancerCare. With AMAZING speakers from @MayoClinic & other GREAT
1
13
44
@DrHKantarjian
Hagop Kantarjian,MD
4 months
SQ blinatumomab is highly effective in R-R ALL with CR/CRh rate of 77%, MRD-negativity rate of 91%, and 12-month OS rate of 63-70%. The 250 µg/500 µg dose was selected as the recommended phase 2 dose. @MDAndersonNews #Leukemia https://t.co/7VIh5lDE8y #leusm
5
29
122
@MKD_BMT
Mohamed Kharfan-Dabaja, MD, MBA
5 months
We are happy to share our recently published clinical practice recommendations on the role of allogeneic hematopoietic cell transplantation and CAR T-cell therapy in chronic lymphocytic leukemia on behalf of #ASTCT @MediHumdani @mshadman @DrAmbuj
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Chimeric antigen receptor T-cell therapy (CAR T-cell) is a new treatment option for relapsed and/or refractory (R/R) chronic lymphocytic leukemia (CLL). Novel therapies including Bruton's tyrosine...
5
17
49
@MKD_BMT
Mohamed Kharfan-Dabaja, MD, MBA
5 months
It is a true honor to host @Dr_AmerZeidan who is presenting an inspiring lecture at our Mayo Clinic Comprehensive Cancer Center grand rounds on advances and remaining challenges in myelodysplastic syndrome. @MayoClinic @RManochakian
4
14
73
@RManochakian
Rami Manochakian MD, FASCO Cancer Education
5 months
📣It is a true pleasure to host Professor @Dr_AmerZeidan A great leader in #HematologicMalignancies & a wonderful colleague from @Yale, giving an outstanding talk at the @MayoClinic FL @MayoCancerCare #GrandRounds on a very important topic: #MyeloDysplasticSyndrome #MDS
1
15
50
@MunshiPashnaMD
Pashna N. Munshi MD
6 months
US Geriatric Assessment Practices for Older Adults Undergoing Hematopo... https://t.co/ocZ7uumqC9 In a first of its kind team effort with a so grateful for the commitment and mentorship by all! @MediHumdani,Andy Artz, Paul Carpenter @ASTCT improving our survey methodologies🤞🏼
0
5
17
@RManochakian
Rami Manochakian MD, FASCO Cancer Education
6 months
1/2🔥🚨@OncoAlert Hot off the press. Just published @SpringerNature #CurrentOncologyReports by our team @MayoCancerCare A #Review Article on: ✅The #Antibody-#Drug #Conjugates (#ADCs) Therapeutic 💊#Revolution in #LungCancer 🫁(#NSCLC & #SCLC). 👇🏻 https://t.co/T79W93M0dY
4
27
63
@RManochakian
Rami Manochakian MD, FASCO Cancer Education
7 months
📣Join us at the 34th ANNUAL @MayoCancerCare Florida #Hematology/#Oncology Reviews at Amelia Island #RitzCarlton (July 2025). Comprehensive #CME #Practical (in-person & virtual) Conference, with AMAZING speakers from @MayoClinic & other GREAT centers. 👇🏼 https://t.co/Ecjns5aW5r
6
21
42